229 related articles for article (PubMed ID: 15003472)
1. Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog.
Preziosi R; Sarli G; Paltrinieri M
J Comp Pathol; 2004; 130(2-3):143-51. PubMed ID: 15003472
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis in squamous cell carcinomas of canine skin: an immunohistochemical and quantitative analysis.
Maiolino P; Papparella S; Restucci B; De Vico G
J Comp Pathol; 2001; 125(2-3):117-21. PubMed ID: 11578126
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor in canine cutaneous fibrosarcomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
J Comp Pathol; 2009 Nov; 141(4):229-36. PubMed ID: 19560781
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical application of an antibody specific for human CD1a to the diagnosis of canine mast cell tumour.
Yhee JY; Hong SW; Yu CH; Doster AR; Blas-Machado U; Lyoo YS; Sur JH
J Comp Pathol; 2008 Jul; 139(1):40-6. PubMed ID: 18602642
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.
Russell DS; Rassnick KM; Erb HN; Vaughan MM; McDonough SP
J Comp Pathol; 2010; 143(2-3):223-6. PubMed ID: 20334872
[TBL] [Abstract][Full Text] [Related]
7. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
8. Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors.
Mukaratirwa S; Chikafa L; Dliwayo R; Moyo N
Vet Dermatol; 2006 Apr; 17(2):141-6. PubMed ID: 16515657
[TBL] [Abstract][Full Text] [Related]
9. Lack of prognostic significance of angiogenesis in canine melanocytic tumours.
Cuitiño MC; Massone AR; Idiart JR
J Comp Pathol; 2012; 147(2-3):147-52. PubMed ID: 22520819
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
Yodavudh S; Tangjitgamol S; Puangsa-art S
J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas.
Luong RH; Baer KE; Craft DM; Ettinger SN; Scase TJ; Bergman PJ
Vet Pathol; 2006 Sep; 43(5):622-31. PubMed ID: 16966439
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
Sabattini S; Bettini G
Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
[TBL] [Abstract][Full Text] [Related]
15. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
16. Mast cells in canine cutaneous hemangioma, hemangiosarcoma and mammary tumors.
Woldemeskel M; Rajeev S
Vet Res Commun; 2010 Feb; 34(2):153-60. PubMed ID: 20127412
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary.
Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Rollason TP
Int J Gynecol Pathol; 2007 Oct; 26(4):395-403. PubMed ID: 17885489
[TBL] [Abstract][Full Text] [Related]
19. Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment.
Welle MM; Bley CR; Howard J; Rüfenacht S
Vet Dermatol; 2008 Dec; 19(6):321-39. PubMed ID: 18980632
[TBL] [Abstract][Full Text] [Related]
20. High COX-2 expression in canine mast cell tumours is associated with proliferation, angiogenesis and decreased overall survival.
Gregório H; Raposo T; Queiroga FL; Pires I; Pena L; Prada J
Vet Comp Oncol; 2017 Dec; 15(4):1382-1392. PubMed ID: 28467670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
